Business
Envoy Medical Announces the Grant of Its 40th U.S. Patent
New Patent Adds to Company's Growing Portfolio of Intellectual Property Focused on Fully Implanted Hearing DevicesWhite Bear Lake, Minnesota--(Newsfile Corp. - December 2, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced that it has received its 40th active U.S. Patent from the United States Patent and Trademark Office. The new patent further strengthens the Company's...
About this update from Envoy Medical, Inc.
[{"type":"text","content":"New Patent Adds to Company's Growing Portfolio of Intellectual Property Focused on Fully Implanted Hearing Devices","length":118,"tagName":"p","attribs":{"class":"nfSubHeading"},"className":""},{"type":"text","content":"White Bear Lake, Minnesota--(Newsfile Corp. - December 2, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced that it has received its 40th active U.S. Patent from the United States Patent and Trademark Office. The new patent further strengthens the Company's intellectual property portfolio, which includes an additional 45 issued foreign patents.","length":486,"tagName":"p"},{"type":"text","content":"U.S. Patent No. 12,485,288, Cochlear Implant Stimulation Calibration, covers proprietary cochlear implant systems designed to enhance performance and reliability. The protected technology enables real time measurement and adjustment of electrical current delivered from the implant's stimulator to the auditory nerve.","length":321,"tagName":"p"},{"type":"text","content":""Announcing the grant of our 40th active U.S. patent is an exciting milestone, especially when you consider the additional 45 foreign issued patents we also have," said Brent Lucas, Chief Executive Officer of Envoy Medical. "Imagine where we could be in another couple of years as new patents issue and we expand upon what we already have? We will continue our commitment to the future of hearing devices and look forward to what our team will think of next. While others will need to focus on protecting the past, we look forward to investing in the future."","length":579,"tagName":"p"},{"type":"text","content":"The Acclaim cochlear implant received Breakthrough Device Designation from the FDA in 2019 and is currently under investigation as part of a U.S. based pivotal clinical trial. For more information on the trial, visit www.envoymedical.com/acclaim-pivotal.","length":254,"tagName":"p"},{"type":"text","content":"To be added to the Envoy Medical email distribution list, please email [email protected] with COCH in the subject line.","length":116,"tagName":"p"},{"type":"text","content":"About Envoy Medical, Inc.Envoy Medical (NASDAQ: COCH) is a hearing health company focused on providing innovat...